LEUVEN, Belgium and BOSTON, Feb. 23, 2021 /PRNewswire/ — ico metrix, world leader in imaging AI solutions for people with neurological conditions, announced the addition of ico brain cva, a stroke solution, to the ico brain portfolio. The announcement follows the FDA-clearance and CE-marking of its image processing software for the analysis and communication of the tissue perfusion state on computer tomography (CT) perfusion scans in patients with ischemic stroke. ico brain cva provides physicians with fast, fully automated, and state-of-the-art insights to support treatment decisions in acute ischemic stroke.
Since 2018, treatment guidelines for stroke have expanded the treatment window for mechanical thrombectomy from 6 to 24 hours. Treatment for ischemic stroke is not without risk and requires careful patient selection based on their tissue status. The automated assessment of tissue parameters in an acute clinical setting by ico brain cva will allow more patients to get the right treatment and can improve patient outcomes and care while increasing efficiency.
“With the launch of ico brain cva we address a persisting need in the treatment of acute ischemic stroke. By democratizing advanced CT perfusion analysis for healthcare systems worldwide we take the next step in our mission to become a holistic brain solution provider,” says Wim Van Hecke, CEO at ico metrix.
“The main challenge of current stroke solutions is correctly identifying the entry point of the injected contrast in the brain. ico brain cva introduces new, patented, deep learning technology into this identification process to achieve a more robust assessment of the infarcted area,” explains Dirk Smeets, CTO at ico metrix.
ico brain cva is a fully-automated CE-marked and FDA-cleared software solution for the quantitative assessment of tissue perfusion on CT. ico brain cva reports the volume of the core and perfusion lesion by quantifying reduced cerebral blood flow, volume, and transit time. The report includes information on the correctness of the selected arterial input function and the quality of the output. ico brain cva is a cloud-based solution, returning a report and perfusion maps straight into your PACS and e-mail inbox.
About ico metrix ico metrix (Leuven, Belgium; Boston, USA) strives for data-driven insights and personalized patient care, supported by artificial intelligence. ico metrixoffers a portfolio of AI solutions to assist healthcare with various challenges; ico brain extracts data from brain MRI and CT scans for the radiological reporting and clinical management of neurological disorders such as multiple sclerosis, brain trauma, epilepsy, stroke, dementia, and Alzheimer’s disease. ico mpanion, a digital platform and mobile app, helps people with MS and their care team to monitor clinical symptoms and treatments efficiently and objectively.
Today, ico metrix is internationally active and integrated into more than 100 clinical practices. In addition, ico metrix supports pharmaceutical companies in phase I-III and Real-World Evidence (RWE) studies through imaging and data services, and digital health strategy.
More info
icometrix.com Press Kit: https://tinyurl.com/icobraincva
Dirk Smeets, CTO [email protected]+32 495 80 16 46
View original content: http://www.prnewswire.com/news-releases/icometrix-expands-icobrain-portfolio-with-ischemic-stroke-solution-301232357.html
SOURCE icometrix
————————
Originally published at https://www.thestreet.com/press-releases/icometrix-expands-icobrain-portfolio-with-ischemic-stroke-solution-15574443 on .
